Heartseed, Inc. (219A) AI Stock Analysis

• Market Cap: ¥43.96B
• Dividend Yield: N/A
• Average Volume (3M): 738.74K
• Price to Earnings (P/E): 239.6
• Beta (1Y): 1.19
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 39
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): N/A
• Shares Outstanding: 22,858,200
• 10 Day Avg. Volume: 469,170
• 30 Day Avg. Volume: 738,736
• PEG Ratio: -2.00
• Price to Book (P/B): 5.17
• Price to Sales (P/S): 12.93
• P/FCF Ratio: 37.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): -130.4
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: ¥1,842.00 ▲(2.11% Upside)
• Action: Reiterated Date: 02/19/26
• Date: Action: Reiterated 02/19/26

The score is driven primarily by the FY2025 financial turnaround (profitability and positive free cash flow) and a strong, low-leverage balance sheet. This is tempered by the prior multi-year loss/cash-burn history and an expensive valuation (high P/E), while technicals are neutral-to-modestly supportive but still below the 200-day trend.

Positive Factors

Conservative balance sheet / low leverage

Near-zero debt and a large equity base provide durable financial flexibility. This reduces refinancing risk, supports sustained R&D and trial funding, and preserves optionality to pursue partnerships or M&A without immediate liquidity stress over the next 2–6 months.

Negative Factors

Prior multi-year losses and cash burn

A history of multi-year losses and cash burn shows earnings volatility and execution risk; absent sustained operational improvements, the company could revert to funding dependence. This legacy increases uncertainty about repeatability of FY2025's turnaround.

Heartseed, Inc. Business Overview & Revenue Model

Company Description

Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan....

How the Company Makes Money

Heartseed, Inc. generates revenue through partnerships with pharmaceutical and biotech companies, offering licensing agreements for its proprietary technologies and products under development. Additional income sources include research and develop...

Read more

Heartseed, Inc. generates revenue through partnerships with pharmaceutical and biotech companies, offering licensing agreements for its proprietary technologies and products under development. Additional income sources include research and develop...

Heartseed, Inc. Financial Statement Overview

Breakdown	Oct 2025	Oct 2024	Oct 2023	Oct 2022
Income Statement
Total Revenue	3.03B	873.61M	344.73M	499.06M
Gross Profit	3.03B	0.00	0.00	0.00
EBITDA	278.71M	-996.98M	-1.45B	-1.46B
Net Income	163.38M	-812.73M	-1.47B	-1.41B
Balance Sheet
Total Assets	8.14B	7.07B	5.72B	4.94B
Cash, Cash Equivalents and Short-Term Investments	7.34B	5.30B	4.59B	3.99B
Total Debt	890.00K	5.39M	11.58M	30.98M
Total Liabilities	571.35M	444.34M	450.19M	208.45M
Stockholders Equity	7.57B	6.62B	5.27B	4.73B
Cash Flow
Free Cash Flow	1.05B	-1.36B	-1.13B	-1.92B
Operating Cash Flow	1.08B	-1.34B	-797.93M	-1.92B
Investing Cash Flow	72.64M	-67.13M	-425.69M	-994.00K
Financing Cash Flow	375.76M	2.12B	1.85B	-22.16M

Heartseed, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1804.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:219A, the sentiment is Positive. The current price of 1804 is below the 20-day moving average (MA) of 1818.30, below the 50-day MA of 1883.64, and below the 200-day MA of 2423.52, indicating a neutral trend. The MACD of -12.17 indicates Negative momentum. The RSI at 57.23 is Neutral, neither overbought nor oversold. The STOCH value of 74.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:219A.

Heartseed, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4350	70 Outperform	¥16.30B	6.83	―	2.32%	6.60%	27.97%
4931	64 Neutral	¥45.03B	10.10	―	2.53%	2.74%	-7.19%
219A	63 Neutral	¥43.96B	239.59	―	―	―	―
3349	60 Neutral	¥524.40B	22.79	―	0.93%	3.73%	18.84%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
2796	48 Neutral	¥6.12B	-12.09	―	2.65%	15.66%	56.93%
190A	47 Neutral	¥9.18B	-6.49	―	―	―	―

Heartseed, Inc. Corporate Events